These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18220951)

  • 1. Evidence for the role of luteinizing hormone in Alzheimer disease.
    Webber KM; Casadesus G; Bowen RL; Perry G; Smith MA
    Endocr Metab Immune Disord Drug Targets; 2007 Dec; 7(4):300-3. PubMed ID: 18220951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of luteinizing hormone to Alzheimer disease pathogenesis.
    Webber KM; Perry G; Smith MA; Casadesus G
    Clin Med Res; 2007 Oct; 5(3):177-83. PubMed ID: 18056027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice.
    Casadesus G; Webber KM; Atwood CS; Pappolla MA; Perry G; Bowen RL; Smith MA
    Biochim Biophys Acta; 2006 Apr; 1762(4):447-52. PubMed ID: 16503402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gonadotropin connection in Alzheimer's disease.
    Meethal SV; Smith MA; Bowen RL; Atwood CS
    Endocrine; 2005 Apr; 26(3):317-26. PubMed ID: 16034187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteinizing hormone as a key player in the cognitive decline of Alzheimer's disease.
    Burnham VL; Thornton JE
    Horm Behav; 2015 Nov; 76():48-56. PubMed ID: 26031357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of luteinizing hormone and testosterone on beta amyloid (Aβ) accumulation: Animal and human clinical studies.
    Verdile G; Asih PR; Barron AM; Wahjoepramono EJ; Ittner LM; Martins RN
    Horm Behav; 2015 Nov; 76():81-90. PubMed ID: 26122291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Luteinizing Hormone in Alzheimer Disease Development in Elderly Women.
    Rao CV
    Reprod Sci; 2017 Mar; 24(3):355-368. PubMed ID: 27436369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease.
    Casadesus G; Zhu X; Atwood CS; Webber KM; Perry G; Bowen RL; Smith MA
    Curr Drug Targets CNS Neurol Disord; 2004 Aug; 3(4):281-5. PubMed ID: 15379604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease.
    Casadesus G; Atwood CS; Zhu X; Hartzler AW; Webber KM; Perry G; Bowen RL; Smith MA
    Cell Mol Life Sci; 2005 Feb; 62(3):293-8. PubMed ID: 15723165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in luteinizing hormone are associated with declines in cognitive performance.
    Casadesus G; Milliken EL; Webber KM; Bowen RL; Lei Z; Rao CV; Perry G; Keri RA; Smith MA
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):107-11. PubMed ID: 17376589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1
    Wang JH; Lei X; Cheng XR; Zhang XR; Liu G; Cheng JP; Xu YR; Zeng J; Zhou WX; Zhang YX
    Alzheimers Res Ther; 2016 Dec; 8(1):57. PubMed ID: 27964740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis.
    Webber KM; Casadesus G; Perry G; Atwood CS; Bowen R; Smith MA
    Alzheimer Dis Assoc Disord; 2005; 19(2):95-9. PubMed ID: 15942328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.
    Barron AM; Verdile G; Martins RN
    Endocrine; 2006 Apr; 29(2):257-69. PubMed ID: 16785601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential means of investigating the role of luteinizing hormone in the pathogenesis of Alzheimer disease.
    Welsh JS
    Clin Med Res; 2008 May; 6(1):1-2. PubMed ID: 18591369
    [No Abstract]   [Full Text] [Related]  

  • 15. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.
    Johnson-Wood K; Lee M; Motter R; Hu K; Gordon G; Barbour R; Khan K; Gordon M; Tan H; Games D; Lieberburg I; Schenk D; Seubert P; McConlogue L
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1550-5. PubMed ID: 9037091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.
    Uemura T; Yanagisawa T; Shirasu K; Matsuyama A; Minaguchi H
    Am J Obstet Gynecol; 1992 Jul; 167(1):283-91. PubMed ID: 1332475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing hormone: Evidence for direct action in the CNS.
    Blair JA; Bhatta S; McGee H; Casadesus G
    Horm Behav; 2015 Nov; 76():57-62. PubMed ID: 26172857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
    Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
    Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social suppression of cortisol in female marmosets: role of luteinizing hormone/chorionic gonadotropin.
    Saltzman W; Hogan BK; Horman BM; Abbott DH
    Gen Comp Endocrinol; 2006 Oct; 149(1):90-9. PubMed ID: 16806216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice.
    Wu Z; Yang B; Liu C; Liang G; Eckenhoff MF; Liu W; Pickup S; Meng Q; Tian Y; Li S; Wei H
    Alzheimer Dis Assoc Disord; 2015; 29(3):184-191. PubMed ID: 25650693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.